US FDA Approves First Reformulated Rx Ranitidine, Five Years After Withdrawal

 
• By Malcolm Spicer
  
The FDA approved VKT Pharma's 150- and 300-mg tablets of histamine H2-blocker ranitidine tablets. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from United States